Clopidogrel Adherence to AHA/ACC Guideline in Patients with Open Heart Surgery in a Tertiary Heart Center
Background: Clopidogrel is an antiplatelet drug that is widely prescribed for cardiovascular disease. In cardiac surgery, it is used in patients after coronary artery bypass grafting (CABG) to prevent coagulation disorders. The irrational use of this drug can lead to bleeding and require surgical ex...
Saved in:
Main Authors: | Naser Safaie (Author), Taher Entezari Maleki (Author), Zainab Alhasan (Author), Nafiseh Hosseini (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
by: Arielle Abovich, et al.
Published: (2023) -
ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016) -
2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues
by: İbrahim Sarı, et al.
Published: (2016) -
Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
by: Rhanderson Cardoso, et al.
Published: (2022) -
USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS BY CARDIOLOGISTS SINCE THE RELEASE OF 2022 AHA/ACC/HFSA GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE
by: Gowtham R. Grandhi, MD MPH, et al.
Published: (2023)